A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
Heart Failure, Heart Failure With Preserved Ejection Fraction
About this trial
This is an interventional treatment trial for Heart Failure
Eligibility Criteria
Inclusion Criteria:
- Prior chronic treatment, or prescription, with a loop diuretic (for example, furosemide, torsemide, bumetanide) for ≥30 days prior to the index event. Index event is defined as a recent hospitalization for HF requiring at least 2 doses of intravenous diuretics or an out- of- hospital encounter (for example, Emergency Room, clinic visit, infusion clinic, etc.) for HF requiring at least 2 doses of intravenous diuretics.
- Chronic HF diagnosed for at least 3 months before V1 (screening).
- Documented LVEF of ≥50% within 6 months prior to screening; as measured by echocardiography, radionuclide ventriculography, invasive angiography, magnetic resonance imaging (MRI), or computerized tomograph (CT).
Had evidence of clinical HF syndrome consisting of
- Hospitalization for HF within the past 2 weeks from randomization, for worsening heart failure (WHF) with intravascular volume overload (the index event), as determined by the investigator, based on appropriate supportive documentation at randomization, and defined by ≥2 of the following:
- dyspnea
- jugular venous distention
- pitting edema in lower extremities (>1+)
- ascites
- pulmonary congestion on chest X-ray
- pulmonary rales AND participant received treatment with IV diuretics.
OR
Treatment for an urgent visit outside of of being hospitalized with WHF and intravascular volume overload (the index visit) requiring treatment with IV diuretics (defined as ≥2 IV doses) such as in the outpatient setting/emergency room/observation unit/infusion clinic with a clinical response within the past 2 weeks prior to randomization. Urgent visit is defined as an unplanned visit for HF defined by ≥2 of the following:
- dyspnea
- jugular venous distention
- pitting edema in lower extremities (>1+)
- ascites
- pulmonary rales on lung examination.
- NT-proBNP (>300 [sinus rhythm] or 900 picograms/milliliter (pg/mL) [atrial fibrillation or atrial flutter] OR brain natriuretic (BNP) (>100 [sinus rhythm] or 300 pg/mL [atrial fibrillation or atrial flutter]) at screening.
Note: The presence or absence of atrial fibrillation or atrial flutter to determine the appropriate cut-off for a given BNP or NT-proBNP sample should be evaluated using electrocardiogram (ECG) performed at screening prior to the collection of the BNP or NT-proBNP sample.
Exclusion Criteria
- Prior documentation of low ventricle ejection fraction (LVEF) ≤45% in the past 12 months.
- Have had acute coronary syndrome or percutaneous coronary intervention, coronary artery bypass graft, cardiac mechanical support implantation, within 3 months prior to day 2. (randomization), or any other cardiac surgery planned during the study.
- Have had Left Ventricular assist device (LVAD) or cardiac transplantation or have cardiac transplantation planned during the study.
- Have hypertrophic cardiomyopathy (obstructive or nonobstructive), restrictive cardiomyopathy, active myocarditis, constrictive pericarditis, cardiac sarcoidosis, known amyloid cardiomyopathy, or inherited cardiomyopathy.
- Have severe chronic obstructive pulmonary disease (COPD) as defined by chronic oxygen dependence. Night-time oxygen is not exclusionary.
- Uncorrected thyroid disease.
Sites / Locations
- Pima HeartRecruiting
- Valley Clinical Trials, Inc.Recruiting
- Valley Clinical Trials, Inc.Recruiting
- University of California Irvine Medical CenterRecruiting
- Pasadena Clinical ResearchRecruiting
- Velocity Clinical Research, Coastal Heart Medical GroupRecruiting
- Excel Medical Clinical TrialsRecruiting
- Infinite Clinical ResearchRecruiting
- South Florida Research Solutions - North Flamingo RoadRecruiting
- University Medical Center New Orleans
- Boston Medical CenterRecruiting
- Henry Ford HospitalRecruiting
- University of North Carolina Medical CenterRecruiting
- Abington Memorial HospitalRecruiting
- PharmaTex ResearchRecruiting
- Baylor Scott & White Health-Advanced Heart and Lung DiseaseRecruiting
- UT Southwestern Medical CenterRecruiting
- University of Texas Medical BranchRecruiting
- West Houston Area Clinical Trial ConsultantsRecruiting
- Texas Institute of Cardiology, PARecruiting
- Instituto de Investigaciones Clinicas ZarateRecruiting
- Centro de Investigaciones Metabólicas (CINME)Recruiting
- Mautalen Salud e InvestigaciónRecruiting
- Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
- Investigaciones Medicas Imoba SrlRecruiting
- Instituto Médico Río CuartoRecruiting
- Instituto de Investigaciones Clinicas Rosario
- Hospital Provincial del CentenarioRecruiting
- Sanatorio San Martin
- Investigaciones Clínicas TucumánRecruiting
- CEMEDICRecruiting
- Fundación RespirarRecruiting
- Hospital de Alta Complejidad "Pte. Juan Domingo Perón"
- Clínica de Nefrología, Urología y Enfermedades CardiovascularesRecruiting
- Centro de Investigaciones Clinicas del LitoralRecruiting
- Universidade Federal de GoiasRecruiting
- PUC Trials- Nucleo de Pesquisa clinica da Escola de Medicina da PUCPRRecruiting
- Centro de Pesquisa Clinica do CoracaoRecruiting
- Instituto de Pesquisa clinica de CampinasRecruiting
- Centro de Pesquisa Sao LucasRecruiting
- Instituto Do Coracao De MariliaRecruiting
- CAPED Centro Avancado Pesquisa e DiagnosticaRecruiting
- Pesquisare SaudeRecruiting
- Incor - Instituto do CoracaoRecruiting
- Instituto de Molestias Cardiovasculares de TatuiRecruiting
- Hospital São Lucas de CopacabanaRecruiting
- Misericordia Community HospitalRecruiting
- SMH Cardiology Clinical TrialsRecruiting
- Cambridge Cardiac Care Centre
- Private Practice - Dr. Saul Vizel
- North York Diagnostic and Cardiac CentreRecruiting
- Oakville Trafalgar Memorial Hospital
- Heart Health Institute - Scarborough OfficeRecruiting
- Fadia El Boreky MedicineRecruiting
- Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai KözpontRecruiting
- Medifarma 98 KftRecruiting
- Flor Ferenc Hospital of Pest CountyRecruiting
- Belvárosi EgészségházRecruiting
- Dél-Pesti CentrumkórházRecruiting
- Semmelweis UniversityRecruiting
- Saiseikai Futsukaichi HospitalRecruiting
- Nakamura Cardiovascular ClinicRecruiting
- National Hospital Organization Takasaki General Medical CentarRecruiting
- Yokohama City University Medical CenterRecruiting
- Yokohama Minami Kyosai HospitalRecruiting
- Kanagawa Cardiovascular and Respiratory CenterRecruiting
- Minamino Cardiovascular HospitalRecruiting
- Ome Municipal General HospitalRecruiting
- Yamanashi Prefectural Central HospitalRecruiting
- Harasanshin HospitalRecruiting
- Rakuwakai Otowa HospitalRecruiting
- National Hospital Organization Okayama Medical CenterRecruiting
- Sakurabashi Watanabe HospitalRecruiting
- Yodogawa Christian HospitalRecruiting
- National Hospital Organization - Osaka National Hospital - Institute For Clinical ResearchRecruiting
- Toyama Prefectural Central HospitalRecruiting
- NZOZ Centrum Medyczne KERmedRecruiting
- INTERCORRecruiting
- CenterMed Lublin NZOZRecruiting
- Private Practice - Dr. Ewa Mirek BryniarskaRecruiting
- MEDICOME Centrum Badań Klinicznych OświęcimskieRecruiting
- KLIMED Marek KlimkiewiczRecruiting
- Szpital Św. Wincentego a Paulo Spółka
- IRMED Osrodek Badan KlinicznychRecruiting
- Provita ProfamiliaRecruiting
- CHUS - Hospital Clinico UniversitarioRecruiting
- Hospital Universitario Virgen de ValmeRecruiting
- Hospital Germans Trias i PujolRecruiting
- Hospital Universitari de BellvitgeRecruiting
- Hospital San Juan de la CruzRecruiting
- Hospital Universitario Ramón y CajalRecruiting
- Hospital Clínico Universitario Virgen de la ArrixacaRecruiting
- Hospital Universitario Virgen de la VictoriaRecruiting
- Hospital Clinico de ValenciaRecruiting
- Hospital Universitario 12 de OctubreRecruiting
- Wycombe General HospitalRecruiting
- Raigmore Hospital
- Northwick Park HospitalRecruiting
- Glasgow Royal InfirmaryRecruiting
- Aintree University Hospital NHS Foundation Trust
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Placebo Comparator
LY3540378 Dose 1
LY3540378 Dose 2
LY3540378 Dose 3
Placebo
Participants will receive LY3540378 subcutaneously (SC).
Participants will receive LY3540378 SC.
Participants will receive LY3540378 SC.
Participants will be given placebo SC.